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Background: In past years research has focused on the development of alternative Gram positive bacterial
expression systems to produce industrially relevant proteins. Brevibacillus choshinensis is an easy to handle
non-sporulating bacterium, lacking extracellular proteases, that has been already shown to provide a high level of
recombinant protein expression. One major drawback, limiting the applicability of the Brevibacillus expression
system, is the absence of expression vectors based on inducible promoters. Here we used the PxylA inducible
promoter, commonly employed in other Bacillae expression systems, in Brevibacillus.
Results: Using GFP, α-amylase and TcdA-GT as model proteins, high level of intracellular protein expression
(up to 250 mg/L for the GFP) was achieved in Brevibacillus, using the pHis1522 vector carrying the B. megaterium
xylose-inducible promoter (PxylA). The GFP expression yields were more than 25 fold higher than those reported for
B. megaterium carrying the same vector. All the tested proteins show significant increment in their expression levels
(2-10 folds) than those obtained using the available plasmids based on the P2 constitutive promoter.
Conclusion: Combining the components of two different commercially available Gram positive expression systems,
such as Brevibacillus (from Takara Bio) and B. megaterium (from Mobitec), we demonstrate that vectors based on the
B. megaterium PxylA xylose inducible promoter can be successfully used to induce high level of intracellular
expression of heterologous proteins in Brevibacillus.
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Recombinant protein expression, Gram positive bacteriaBackground
Bacterial expression systems for heterologous protein
production are attractive because of the ability of the
host cell to grow rapidly and at high density on inexpen-
sive substrates. Escherichia coli is the most extensively
used bacterial host for production of recombinant pro-
teins. In spite of its large employment, E. coli has several
disadvantages that limit its applicability in the industrial
production of proteins: 1) The expression of recombinant
proteins often results in their accumulation as insoluble
aggregates in inclusion bodies; 2) The separation of lipo-
polysaccharide (LPS), generally referred as pyrogenic endo-
toxins, requires the introduction of additional expensive
purification steps [1]. Therefore in past years, research has* Correspondence: manuele.martinelli@novartis.com
Novartis Vaccines and Diagnostics, Via Fiorentina 1, 53100, Siena, Italy
© 2013 D'Urzo et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orfocused on the development of an alternative bacterial
expression system. Gram positive bacteria do not produce
LPS and are able to export proteins directly into the
extracellular medium. Several expression systems for
heterologous protein production in Gram positive bacteria,
especially Bacilli, have already been successfully used to
produce a number of industrial relevant proteins [2,3]. Re-
cently Takara Bio has released a Brevibacillus choshinensis
(previously known as Bacillus brevis) expression system
that is reported to guarantee high levels of extra cellular
protein expression [4] although few data are available
about the performance of the intracellular expression
[5]. Although less characterized than B. subtilis and B.
megaterium, Brevibacillus choshinensis HPD31-SP3
(Brevibacillus) presents attributes that make it an
advantageous host for heterologous protein production.
A simple protocol to induce competence for DNALtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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is available from Takara Bio. Brevibacillus readily grows
up to high cell density in shake flasks using either com-
plex or chemically defined media suitable for uniform
15N isotopic protein labelling [6]. Moreover, similarly to
B. megaterium, the commercially available Brevibacillus
strain does not form spores and presents limited intra-
cellular and extracellular protease activities. All these
aspects together make this bacterium attractive because
it is more user-friendly compared to other Gram posi-
tive microorganisms. A clear disadvantage though is
that all the commercially available expression vectors
designed for Brevibacillus choshinensis SP3 rely on con-
stitutive promoters and therefore do not allow a tightly
controlled gene expression. This poses a limit to the
expression of foreign proteins potentially toxic to the
host cell and can impact on the final yield because of a
sustained metabolic burden.
Efficient sugar-inducible promoters such as Plac,
Pbad, and rhaPbad of E. coli [7-9] and Pxyl of Bacillus
subtilis [10] are widely used to optimize gene expression
in the respective micro-organisms. For the Bacillae, one
of the most commonly employed expression system is
based on the PxylA inducible promoter of the xyl
operon, which is usually localized on a freely replicating
plasmid containing a copy of the xylR gene along with it
[11]. Repression of promoter activity in the absence of
the inducer xylose is mediated by the repressor protein
XylR. The selection of microbial hosts able to uptake
xylose but deficient in its utilization is essential to main-
tain the concentration of the inducer constant during cul-
tivation and achieve high expression yields [3]. D-xylose
metabolism in bacteria typically involves transport,
isomerization to D-xylulose, and phosphorylation to D-
xylulose-5-phosphate. The second and third steps of this
pathway are catalyzed by D-xylose (D-glucose) isomerase
(XylA) and xylulose kinase (XylB), respectively [12], while
xylose uptake is mediated via at least two distinct trans-
port systems: one involves a D-xylose–H+ or –Na+ sym-
porter (XylE/XylT) [13,14]. The second mechanism
consists of genes for xylose ABC transport form a
xylFGHR operon in which xylF, xylG, and xylH code for
the periplasmic xylose-binding protein, ATPase, and
permease, respectively [15].
No xylA homologues were found in the Brevibacillus
brevis NBRC 100599 genome supporting that, as
already reported, Brevibacillus species do not ferment
D-xylose [16]. However, the outcome of a xylose induc-
tion system in Brevibacillus is not obvious because no
homologues of the XylE/XylT and XylFGH systems,
involved in D-xylose uptake in other organisms [17],
are present in the Brevibacillus genome.
To confirm the suitability of a PxylA promoter in
Brevibacillus, we compared the intra/extra-cellularexpression level of the green fluorescent protein (GFP)
[18], α-amylase from B. licheniformis [19] and the Y283A-
D285A-D287A mutant of TcdA catalytic domain from
Clostridium difficile (TcdA-GT) [5], using the xylose-
inducible promoter PxylA and the strong constitutive
promoter P2. Here we show that the PxylA xylose indu-
cible promoter is able to induce high levels of intracellular
expression of heterologous protein in Brevibacillus.Results
Sequence Search
The Brevibacillus genome was analyzed to find homolo-
gues of the proteins known to be involved in xylose uptake
and metabolism in other organisms and therefore to
evaluate its suitability as a host for protein expression
using the xylose induction. A PSI-BLAST search (E <0,1)
was performed to detect putative xylose import systems
in the Brevibacillus brevis NBRC 100599 genome. No
homologues with high a degree of identity to the XylA,
XylE and XylF genes were found. When using the E. coli
XylA (GenBank: NP_418022) as input, no putative
homologues were found in the Brevibacillus brevis NBRC
100599 genome. The BLAST search using the E. coli XylE
(GenBank: NP_418455) as input could only identify an
alpha-ketoglutarate permease (YP_002770906) with low
sequence identity with E. coli XylE (20% identity) and
B. megaterium XylT (18,5% identity). The BLAST search
using E. coli XylF (GenBank: AAB18543) as input revealed
two putative ABC transporter substrate binding proteins
(mglb and BBR47_06790). The mglb protein showed
23,8% identity with XylF and the absence of 3 of the 5 xy-
lose binding residues [20], (D135, N137, K242). The
BBR47_06790 showed 17,8% identity when compared to
XylF and once again the absence of 3 of the 5 xylose
binding residue D135, N196, K242.Brevibacillus growth profile in complex and minimal
media
First, we determined the rate of growth of Brevibacillus in
shaking flask containing TM medium and incubated at
different temperatures (Additional file 1: Figure S1). A
final OD600 of about 5 was obtained growing Brevibacillus
in a temperature range between 25°C and 37°C, while no
significant growth was observed at 20°C after 120 h. To
confirm the inability to metabolize xylose, Brevibacillus
was cultured in minimal medium with either glucose or
xylose as unique carbon source. After 24 h of culture at
37°C, 150 rpm in shaking flask, no growth (OD600 <0,1)
was observed for Brevibacillus using chemically defined
medium containing xylose while an OD600 of about 1 was
detected for Brevibacillus grown in the same media
containing glucose.
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GFP production by Brevibacillus carrying the GFP-
pHis1522 induced with different amounts of xylose was
compared to cultures transformed with the GFP-pNI
vector. The influence of temperature on protein yield
was assessed for all clones by western blot analysis and
fluorescence intensity determination (Figure 1). The
GFP-pNI Brevibacillus clone showed a maximum of
total GFP production at 30°C after about 40 h (5585
Fluorescence Unit (F.U.) /OD600) (Figure 1A). Different
incubation temperatures affected the rate of synthesis of
GFP (Figure 1A) also if comparable final yields of total
protein were obtained at 25°C and 30°C. The GFP-
pHis1522 Brevibacillus clone showed maximum GFP
production at 30°C about 48 h after induction with 0,5%
of xylose (83379 F.U./OD600) (Figure 1B). The xylose
concentration slightly affects both the rate of protein
expression and total protein yield (Additional file 2:
Figure S2A) confirming the inability of Brevibacillus to
metabolize the xylose. In this range of temperatures, the
GFP expression levels, induced by xylose, are about 10
fold higher with respect those achievable with the GFP-
pNI (Figure 1). No significant basal expression of GFP
was detected growing Brevibacillus carrying GFP-
pHis1522 for 96 h without induction, confirming thatFigure 1 Time course of intracellular GFP production by Brevibacillus
Brevibacillus cells carrying GFP-pNI grown at 37°C (red line), 30°C (green lin
GFP-pHis1522 grown at 37°C (red line), 30°C (green line), 25°C (blue line) C
30°C D) Western blot of Brevibacillus cells carrying GFP-pHis1522 grown at
and GFP-pHis1522 after 48 h of growth at 37°C, 30°C, 25°C (about 20 OD60
were centrifuged and the image was carried out from the cell pellet using
and each experiment was performed at least twice. Error bars indicate stanprotein expression is repressed in absence of xylose
(Figure 1). At 37°C the performance of both inducible
and non inducible vectors were drastically reduced.Intracellular α-amylase expression in Brevibacillus
α-amylase production by Brevibacillus carrying the
α-amylase-pHis1522 induced with 0,5% of xylose was
compared to those obtained with the α-amylase-pNI
vector. The influence of temperature on protein expression
was assessed for all clones by western blot analysis and by
measuring the amylase activity after 48 and 120 h of
induction. Both α-amylase-pNI and α-amylase-pHis1522
Brevibacillus clones showed a maximum of total protein
production at 25°C after about 120 h of culture (60 U/mL
and 123 U/mL respectively) (Figure 2) while at 37°C and
30°C the performance of both inducible and non indu-
cible vectors were reduced. Interestingly the expression
in pHis1522 vector was more than 2 fold higher com-
pared to those achievable with the GFP-pNI vector
(Figure 2). No significant basal expression of α-amylase
was detected growing Brevibacillus carrying GFP-pHis1522
for 120 h without induction, confirming that protein
expression is repressed in absence of xylose (Figure 2A
and 2B).choshinensis SP3 at different temperatures. A) GFP fluorescence of
e), 25°C (blue line) B) GFP fluorescence of Brevibacillus cells carrying the
) Western blot analysis of Brevibacillus cells carrying GFP-pNI grown at
30°C E) Fluorescence imagine of Brevibacillus cells carrying GFP-pNI
0). The GFP-pHis1522 was induced with 0,5% of xylose. 5 mL of culture
ImageQuant 400 (GE Healthcare). All cultures were grown in triplicate,
dard deviations.
Figure 2 Time course of intracellular α-amylase and TcdA-GT production by Brevibacillus choshinensis SP3 at different temperatures.
A) α-amylase activity of Brevibacillus lysate carrying α-amylase-pNI and α-amylase-pHis1522 grown in at 37°C (red line), 30°C (green line), 25°C
(blue line) B) Western blot of Brevibacillus cells carrying α-amylase-pNI and α-amylase-pHis1522 grown at 25°C C) Western blot of Brevibacillus cells
carrying TcdA-GT-pNI and TcdA-GT-pHis1522 grown at 25°C α-amylase-pHis1522 and TcdA-GT-pHis1522 were induced with 0,5% of xylose. All
cultures were grown in triplicate, and each experiment was performed at least twice. Error bars indicate standard deviations.
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TcdA-GT production by Brevibacillus carrying the
TcdA-GT-pHis1522 induced with 0,5% of xylose was
compared to those obtained with the α-amylase-pNI
vector. The influence of temperature on protein yield
was assessed for all clones by performing SDS-PAGE
analysis and BCA quantification of the IMAC purified
samples (Figure 2C). In both TcdA-GT-pNI and TcdA-
GT-pHis1522 Brevibacillus clones, the best results in
terms of protein expression and stability were observed
at 25°C, while lower expression levels were detected
using both vectors at 37°C and 30°C as already observed
for α-amylase (data not shown).
Extracellular GFP expression in Brevibacillus
GFP production by Brevibacillus carrying the SEC-
GFP-pHis1522 induced with different amounts of xylose
was compared to those obtained with the GFP-pNC
vector. The influence of temperature on protein yield was
assessed for all clones by western blot analysis and fluor-
escence intensity determination (Figure 3). As already
observed for intracellular expression, GFP-pNC and SEC-
GFP-pHis1522, showed the best performance at 25-30°C(Figure 3A and 3B). The GFP-pNC Brevibacillus clone
showed the peak of fluorescence in the supernatant after
72 h of growth (3859 F.U.) (Figure 3A and 3C); the SEC-
GFP-pHis1522 Brevibacillus clone showed maximum
GFP production after about 74 h of induction with 0,5%
of xylose (2157 F.U.) (Figure 3B and 3D). As already
observed for the intracellular expression, the xylose
concentration had a minor effect on the total protein yield
(Additional file 2: Figure S2B) and no significant basal ex-
pression was detected in SEC-GFP-pHis1522 Brevibacillus
clone (Figure 3B). At 25°C and 30°C the maximum
expression levels, achievable with the PxylA promoter,
were similar to those obtained with the P2 promoter
(Figure 3) and significantly lower than those achievable
with the intracellular expression. No detectable GFP
production was observed at 37°C with either of the two
plasmids.
Extracellular α-amylase expression in Brevibacillus
α-amylase production by Brevibacillus carrying the
SEC-α-amylase-pHis1522 induced with 0,5% of xylose
was compared to those obtained with the α-amylase-pNC
vector. The influence of temperature on protein yield was
Figure 3 Time course of extracellular GFP production by Brevibacillus choshinensis SP3 at different temperatures. A) GFP fluorescence of
culture supernatant of Brevibacillus carrying GFP-pNC grown at 37°C (red line), 30°C (green line), 25°C (blue line) B) GFP fluorescence of culture
supernatant of Brevibacillus carrying the SEC-GFP-pHis1522 grown at 37°C (red line), 30°C (green line), 25°C (blue line) C) Western blot of the
culture supernatant of Brevibacillus carrying GFP-pNC grown at 25°C D) Western blot of the culture supernatant of Brevibacillus carrying SEC-GFP
-pHis1522 grown at 25°C. SEC-GFP-pHis1522 was induced with 0,5% xylose. All cultures were grown in triplicate, and each experiment was
performed at least twice. Error bars indicate standard deviations.
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measuring the amylase activity at 48 and 120 h of induc-
tion (Figure 4). The α-amylase-pNC Brevibacillus clone
showed a maximum of total protein production at 25°C
after about 120 h of culture (35 U/mL) (Figure 4A)
while at 37°C and 30°C the performances were reduced.
The expression level achievable with the PxylA pro-
moter was not affected by the temperature and, in allFigure 4 Time course of extracellular α-amylase production by Brevib
activity of culture supernatant of Brevibacillus carrying α-amylase-pNC and SEC
(blue line) B) Western blot of the of culture supernatant of Brevibacillus carryin
α-amylase-pHis1522 was induced with 0,5% of xylose. All cultures were grown
bars indicate standard deviations.tested conditions, was lower than that obtained with the
P2 promoter (Figure 5).
Purification of the recombinant GFP and TcdA-GT
To quantify the amount of recombinant GFP and TcdA-
GT produced by different expression vectors, 50 mL of
each culture was collected at the peak of fluorescence,
purified by IMAC chromatography and the amount ofacillus choshinensis SP3 at different temperatures. A) α-amylase
-α-amylase-pHis1522 grown at 37°C (red line), 30°C (green line), 25°C
g α-amylase-pNC and SEC-α-amylase-pHis1522 grown at 25°C.The
in triplicate, and each experiment was performed at least twice. Error
Figure 5 GFP, α-amylase, and TcdA-GT production yield in Brevibacillus SP3. Comparison of the maximum yield obtained for each protein/
vector combination used in this study. All cultures were grown in triplicate and the reported values correspond to the average.
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confirms that pHis1522 induces higher level of GFP and
TcdA-GT intracellular protein expression compared to
the pNI-His vector. However, no improvement of extra-
cellular protein production was observed using pHis1522
in comparison to pNC-His vector, using the same secretion
signal peptide. In fact, the GFP-pHis1522 clone produced
the highest protein yield (250 mg/L) (Figure 5) with
roughly a 10 fold higher yield compared to all the other
tested clones and TcdA-GT-pHis1522 clone produced
about 3 fold higher yield than TcdA-GT-pNI clone
(15 mg/L vs 6 mg/L) (Figure 5). In contrast, the yield
achieved using the SEC-GFP-pHis1522 (20 mg/L) was
slightly lower than that obtained when using the GFP-
pNC vector (30 mg/L). These values are in agreement
with the relative amount of GFP predicted using the
fluorescence assay.
Discussion
In recent years, various studies have revealed that non-
pathogenic Gram positive Bacillae are attractive hosts
for the expression of heterologous proteins. They show
in fact several favourable features, such as the natural
capacity to secrete which allows the exporting of pro-
teins directly into the extracellular medium, and the
absence of endotoxins which make it highly attractive
for the industrial production of pharmaceutical pro-
teins. Several factors including (1) lack of suitableexpression vectors, (2) plasmid instability, (3) presence
of proteases, (4) lack of spore deficient strains, and (5)
low transformation efficiency, limit the choice of
expression systems based on Bacillae with respect to
E. coli. Recently, Takara Bio has released a Brevibacillus
Expression System that overcomes the majority of these
limitations by combining an easy to handle expression
host with the most favorable features typical of Gram
positive bacteria. A number of different proteins such
as bacterial α-amylase [21], cholera toxin B subunit B
[22], human epidermal growth factor [23] and human
interleukin-2 [24] have already been successfully
secreted in high amounts by using this system. Moreover,
the intracellular expression, though less explored, has re-
cently permitted the production of GT-domain of clostrid-
ial TcdA [5]. In this work for the first time, we successfully
employ the PxylA inducible promoter of B. megaterium
to produce heterologous proteins in Brevibacillus. The
selection of an expression host able to import the xylose
into the cells but deficient in its utilization is essential
to maintain a constant level of inducer during the
culture and to achieve a high efficiency of target gene
induction. A BLAST search across the Brevibacillus
brevis NBRC 100599 genome did not reveal any XylA
and XylB homologues. These findings, coupled with the
inability of Brevibacillus to grow in minimal medium
with xylose as the sole carbon source, confirm that,
differently from B. megaterium [25], the Brevibacillus
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utilization. In agreement with this, the use of pHis1522 vec-
tor, carrying the xylose inducible promoter in Brevibacillus,
allow a high level of intracellular protein expression.
The yield obtained for GFP (250 mg/L) is more than 25
fold higher than that reported for B. megaterium carry-
ing the same expression vector [26], more than 10-fold
higher compared to that obtained with Brevibacillus
carrying the GFP-pNI vector (Figure 5) based on the P2
constitutive promoter and, finally, comparable with
E. coli in a fed-batch cultivation [27]. The yields
obtained for both α-amylase and TcdA-GT using the
pHis1522 vector were about 2-3 fold higher compared
to those obtained using the pNI-His vector. In addition
"non-induced cultures" (Figures 1, 2, 3 and 4) confirmed
that protein expression is well repressed in absence of
xylose. The protein induction was maintained for long
term after the addiction of xylose (up to 60-120 h) and
the expression level was not affected by the xylose
concentration. Consequently Brevibacillus is deficient
in the xylose utilization but is also able to uptake the
sugar into the cells even in absence of the representative
genes required for xylose transport. Further investigations
will be necessary to understand if an alternative uncharac-
terized xylose import system is present in Brevibacillus or
whether the uptake of xylose could occur via a transporter
with broad substrate specificity, as already observed
with B. subtilis [28]. On the other hand, the levels of
secreted proteins obtained using both the pNC-His and
pHis1522 vectors were lower than expected and com-
parable to those obtained with pNI-His. While no pub-
lished data are available regarding the GFP production
using Brevibacillus, a high level of α-amylase produc-
tion was already reported using the same expression vector
[29]. The low yields obtained using the SEC-GFP-pHis1522
may not be due to the low efficiency of the xylose induction
system that performs robustly in terms of intracellular
protein expression, but rather to the saturation of the
protein secretion system. Further investigation will be
necessary to understand if the replacement of the
Brevibacillus R6L2 signal peptide with others derived
from Brevibacillus or B. megaterium could properly
enhance the secretion ability of Brevibacillus in
pHis1522, carrying the PxylA B. megaterium promoter.
However, the good performance that the xylose indu-
cible promoter showed in terms of intracellular protein
expression, the absence of LPS and the simple lysis
method make Brevibacillus attractive, in particular for
all those proteins that, similarly to TcdA-GT, are
poorly expressed, toxic or degraded in E. coli
Conclusions
Here we demonstrated, for the first time, that the PxylA
inducible promoter of B. megaterium can efficientlyinduce long term expression of heterologous proteins in
Brevibacillus. Xylose induction in Brevibacillus produces
up to 250 mg/L of intracellular GFP in shake flask
cultures. The availability of controllable vectors, carrying a
well repressed and regulated promoter, could largely
extend the application of Brevibacillus in protein produc-
tion. In conclusion, by shuffling the components of two
different commercially available Gram positive expression
systems, such as Brevibacillus (from Takara Bio) and
B. megaterium (from Mobitec), we created a new original
blend of potential advantage for proteins that in E. coli are
either degraded or poorly expressed.
Methods
Chemicals and enzymes
α-amylase from Bacillus licheniformis (catalog number
A-4551), anti-α-amylase antibody produced in rabbit
(catalog number A8273-1VL), D-(+)-xylose (catalog
number W360600), and antibiotics were purchased
from Sigma Chemical Co. (St. Louis, MO, USA). The
EnzChek_Ultra amylase assay kit (catalog number
E33651) and the polyclonal anti-GFP Rabbit Serum
(catalog number A6455) were purchased from Life
Technologies Corp. (Carlsbad, CA, USA). ECL Western
Blotting Detection Reagents (catalog number RPN2106),
Amersham Hyperfilm ECL (catalog number 28-90-68-37)
were purchased from GE Healthcare (Chalfont St. Giles,
United Kingdom).
Sequence Search
A protein BLAST search (E <0,1) [30] was performed in
order to detect putative E. coli XylA, XylE, XylT and
XylF homologues in the Brevibacillus brevis NBRC
100599 genome. A further BLAST search was performed
to detect the genes codifying for putative XylG, XylH
and XylR homologues and verify their respective
genomic localization in Brevibacillus.
Vectors modification
A new version of pNI-His, pNC-His (Takara Bio) and
pHis1522 (Mobitec) vectors (respectively pNI/ccdB, pNC/
ccdB and pHis1522/ccdB) were constructed to express N-
term His tagged proteins and to limit the background of
transformants coming from the empty vectors in the PIPE
cloning. The His-TEV-CcdB-Chloramphenicol cassette
was amplified from the SpeedET vector [29] using the
ccdB_F and ccdB_R primers (Additional file 3: Table S1)
and cloned into the multicloning sites (MCS). The pNI-
His, pNC-His and pHis1522 vectors were amplified using
the VpNI_F/VpNI_R primers, VpNC_F/ VpNC_R primers
and VpHis1522_F/VpHis1522_R primers respectively
(Additional file 3: Table S1). The unpurified insert-PCR
(I-PCR) and vector-PCR (V-PCR) were mixed 1:1 (v/v)
D’Urzo et al. Microbial Cell Factories 2013, 12:12 Page 8 of 11
http://www.microbialcellfactories.com/content/12/1/12and transformed in 25 μL of E. coli DB3.1 competent cells
(Additional file 4: Table S2).
Gene cloning
To compare the efficiency of protein expression with
the two promoters P2 (Brevibacillus) and PxylA (B.
megaterium), the gfp gene of the green fluorescent pro-
tein (GFP) and the α-amylase gene from B. licheniformis
[19] were introduced into pNI-His and pNC-His
(Takara Bio) leading respectively to intra- and extracel-
lular expression, and pHis1522 (Mobitec), which per-
mits intracellular expression (Table 1 and Additional
file 4: Table S2). The R6L2 signal-peptide coding region
[31] was inserted into the GFP-pHis1522 vectors to
build the SEC-GFP-pHis1522 (Table 1).
In this study a GFP variant, called GFPmut1 or
enhanced green fluorescent protein (EGFP) with amino
acid exchanges in the chromophore (F64L, S65T) was
used (here referred to as GFP). This double amino acid
exchange results in a shift of about 100 nm in the exci-
tation maximum to 490 nm compared to the wild-type
GFP and also in a 30-fold increase of fluorescence
intensity.
Moreover, to compare the intracellular expression using
P2 and PxylA promoters, the Y283A-D285A-D287A mu-
tant of TcdA catalytic domain from Clostridium difficile
was amplified from TcdA-GT-pNI [5] and introduced
into pHis1522 (Mobitec) (Table 1). To construct the
GFP-pNI and GFP-pNC expression vectors (Table 1),
the GFP [32] gene was amplified by PCR using the
GFP_BamHI_F and GFP_XhoI_R primers (Additional
file 3: Table S1). The PCR products were digested with
BamHI/XhoI and then ligated respectively into the
pNI-His and pNC-His vectors using E. coli TOP10
(Additional file 4: Table S2). The recombinant GFP-
pHis1522, α-amylase-pNI, α-amylase-pNC, α-amylase-
pHis1522 and TcdA-GT-pHis1522 expression vectors











TcdA-GT-pHis1522 Intracellular PxylAextension (PIPE) method [33]. The selected genes were
amplified by PCR using the F-GFP/R-GFP primers, F-amy
/R-amy primers and F-tcdA/R-tcdA primers respectively,
which included extensions complementary to the desired
vector cloning site. The pNI/ccdB, pNC/ccdB and
pHis1522/ccdB vectors were then amplified by PCR using
the Vp_F/Vp_R primers (pNI-His and pNC-His vectors)
and the ForpHis1522/RevpHis1522 primers (pHis1522
vector) (Additional file 3: Table S1). The unpurified I-PCR
and V-PCR were mixed 1:1 (v/v) and the mixture was
transformed in 25 μL of E. coli HK100 competent cells
(Additional file 4: Table S2). The R2L6 signal-peptide [31],
a modified version of the signal peptide (SP) coding region
of the Brevibacillus cell wall protein (CWP) gene was
added at the N-term of GFP- α-amylase- sequences in the
pHis1522 clone to generate the SEC-GFP-pHis1522 and
SEC-α-amylase-pHis1522 expression vectors [34]. The
GFP-pHis1522 and α-amylase-pHis1522 vectors were
amplified by PCR using the SecGFP_F/SecGFP_R and
SecAmylase_F/SecAmylase_R primers, which included
19bp complementary extensions coding for the R2L6
signal peptide. A 2 μL aliquot of unpurified vector-PCR
product was transformed in 25 μL of E. coli HK100
competent cells. The vectors were amplified in E. coli,
extracted with a The E.Z.N.A.W Plasmid Mini Kit II
(Omega Biotek, GA, USA) and their DNA sequences were
confirmed by DNA sequencing.Growth medium composition
TM medium (1% glucose, 1% polypeptone, 0,5% meat
extract, 0,2% yeast extract, 0,001% FeSO4 ×7H2O,
0,001% MnSO4 ×4H2O, and 0,0001% ZnSO4 ×7H2O)
and minimal medium (0,85% Na2HPO4 ×2H2O, 0,3%
KH2PO4, 0,3% glucose or xylose, 0,1% (NH4)2SO4, 0,05%
NaCl; 0,01% MgSO4, 0,0001% Biotin, 0,0001% trace
element solution) were used to grow Brevibacillus
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An pre-culture of Brevibacillus grown in TM medium at
30°C, 150 rpm for 16 h and then diluted 100 times in 50
mL of minimal medium containing alternatively 1,5%
glucose or 1,5% xylose as unique carbon source. The
bacterial cells were grown in a 250 mL shaking flask at
37°C, 150 rpm 24 h.
Bacterial transformation
Brevibacillus competent cells were prepared according to
the manufacturer’s instructions (Takara Bio Inc., Shiga,
Japan). All the expression vectors were transformed into
Brevibacillus choshinensis SP3 using the tris-polyethylene
glycol method [4] as described by Takara Bio manual
using 0,5-2 μg of total DNA. 10 μg/mL of neomycin and
20 μg/mL of tetracycline were respectively used to trans-
form the plasmid constricts.
Shaking-flask production of recombinant GFP, α-amylase
and TcdA-GT using Brevibacillus
To screen for protein production freshly transformed cells
were grown overnight in 10 mL of TM medium contain-
ing 10 μg/mL of neomycin (pNI-His and pNC-His
vectors) or 20 μg/mL of tetracycline (pHis1522 and SEC-
pHis1522 vectors) at 30°C, 150 rpm. Pre-inoculums were
inoculated 1:100 in 50 mL of the same media and grown
at 150 rpm at 25°C, 30°C and 37°C. Recombinant expres-
sion of the selected proteins under transcriptional control
of the xylose-inducible promoter, were induced by the
addition of xylose at different concentrations (0,5-1-2%) at
OD600 about 1,5. Intracellular GFP, α-amylase and TcdA-
GT samples were withdrawn at different growth phases,
and subjected to Western blotting analysis, GFP fluor-
escence determination and α-amylase activity assay as
described below.
GFP fluorescence assay
Recombinant GFP production was monitored via fluor-
escence spectroscopy on a black flat bottom 96 well
using a Tecan Infinite M200 reader (Tecan, Mannedorf,
Switzerland). The excitation wavelength was 395 nm
(bandwidth 10 nm) and the emission spectrum was re-
corder with gain 80 in the 420-600 nm range (band-
width 10 nm). To eliminate background fluorescence,
the intensity recorded at 480 nm was subtracted from
that recorded at 510 nm.
1 OD600 of each bacterial culture was collected and
centrifuged. To monitor the intracellular expression of
GFP (for GFP-pNI and GFP-pHis1522 clones), the cell
pellet was washed with 1 mL of PBS and finally resus-
pended in 100 μL of PBS. To reduce the fluorescence
background due to the media, and reveal the secreted
GFP (GFP-pNC and SEC-GFP-pHis1522 clones), the
supernatant was diluted up to 2 mL with PBS buffer andsubsequently concentrated (from 2 mL to 200 μL), using
Amicon Ultra-0.5 10 KDa (Millipore, Billerica, USA) for
2 times. A final volume of 100 μL was finally transferred
into the 96-black flat bottom well plate (Greiner Bio-One,
Frickenhausen, Germany) and the fluorescence emission
spectra were recorded. The GFP fluorescence (expressed
as fluorescence unit = F.U.) was monitored to evaluate the
relative amount of protein expressed under the different
conditions tested.α-amylase quantification
To qualitatively and quantitatively asses the ability of
the different expression vector to produce α-amylase in
Brevibacillus, the α-amylase activity was measured by
EnzChek amylase Assay Kit (Life Technologies Corp.,
Carlsbad, CA, USA). Briefly, the culture supernatant
(SEC-α-amylase-pHis1522) or the Brevibacillus lysate
(α-amylase-pHis1522) was mixed with 200 μg/mL of
substrate solution (starch-BODIPY FL conjugate) and
incubated for 30 minutes at 25°C. Fluorescence intensity
was measured at excitation and emission wavelengths of
470 and 530 nm in an Infinite M200 spectrophotometer
microplate reader (Tecan, Mannedorf, Switzerland).
Analysis of culture supernatant and Brevibacillus lysate
from the GFP-pHis1522 and SEC-GFP-pHis1522 clones
were also performed as negative control.Western Blot analysis
To analyze the intracellular expression, the bacterial cells
were suspended in CelLytic Express (Sigma-Aldrich, St.
Louis, MO, USA) incubated at 25°C for 30 minutes and
the cellular debris was removed by centrifugation. Soluble
fractions, derived from 0,08 OD600 of lysed bacteria, were
loaded and resolved on 4-12% NuPAGE precast gels (Life
Technologies Corp. Carlsbad, CA, USA) and transferred
to nitrocellulose. To analyze the extracellular expression,
the bacterial cells were centrifuged and 20 μL of culture
supernatant were loaded and resolved on 4-12% NuPAGE
precast gels (Life Technologies Corp., Carlsbad, CA, USA)
and transferred to nitrocellulose. In both cases, the
membranes were probed with rabbit antibodies directed
against GFP (1:100 dilution) or against α-amylase
(1:1000 dilution), followed by a rabbit anti-rabbit horse-
radish peroxidase-conjugated secondary antibody (Dako,
Glostrup, Denmark). Bands were then visualized using an
Opti-4CN substrate kit (Bio-Rad Laboratories, Hercules,
CA) or SuperSignal West Pico chemiluminescent substrate
(Pierce, IL, USA).
Western Blot analysis were performed for all the con-
ditions (37, 30 and 25°C) but we reported in Figures 1,
2, 3, 4 only that one providing the highest levels of
protein expression, as estimated by GFP fluorescence
assay or amylase activity assay Kit.
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GFP and TcdA-GT purification by IMAC chromatography
was performed to better estimate the protein yields achiev-
able for each strain/vector combination. For purification of
intracellular GFP and TcdA-GT, cells were harvested by
centrifugation, re-suspended in 10 mL of binding buffer
(Tris 20 mM, NaCl 300 mM, Imidazole 10 mM, pH=8,0)
and finally disrupted by sonication. Cellular debris were
removed by centrifugation (8000 rpm, 4°C, 30 min). The
supernatant was loaded onto a PD-10 gravity flow column
(GE Healthcare, Chalfont St. Giles, United Kingdom),
packed with 2 mL of Ni-NTA FF resin (Qiagen, Hilden,
Germany). For purification of extracellular GFP, cells were
harvested by centrifugation, culture supernatant was
filtered through a 0,22 μm filter (Millipore, Billerica, USA)
and loaded onto a column prepared as indicated above. 2
washing step were perfomed using 40 mL of binding buffer
and 40 mL of washing buffer (Tris 20 mM, NaCl 300 mM,
Imidazole 20 mM pH=8,0) and the bound protein was then
eluted with the elution buffer (Tris 20 mM, NaCl 300 mM,
Imidazole 300 mM pH=8,0). SDS-PAGE and BCA assay
(Pierce, IL, USA) were used to check protein purity and
concentration, respectively.Additional files
Additional file 1: Figure S1. Temperature dependent growth rate of
Brevibacillus choshinensis SP3. Shaking flask cultivation of Brevibacillus
choshinensis SP3 carrying the pNI-His vector. All cultures were grown in
triplicate, and each experiment was performed at least twice. Error bars
indicate standard deviations.
Additional file 2: Figure S2. Time course of intra- and extracellular GFP
production by Brevibacillus choshinensis SP3 at different xylose
concentration. A) GFP fluorescence of Brevibacillus carrying the
GFP-pHis1522 grown in at 25°C induced by adding different amounts of
xylose (0,5% (solid line) - 1% (dashed line) - 2% (round dots)). B) GFP
fluorescence of culture supernatant of Brevibacillus carrying SEC-GFP
-pHis1522 grown at 25°C induced by adding different amounts of xylose
(0,5% (dashed line) - 1% (solid line) - 2% (round dots)). All cultures were
grown in triplicate, and each experiment was performed at least twice.
Error bars indicate standard deviations.
Additional file 3: Table S1. Primers used in this study (regular:
complementary overlap; bold: restriction enzyme recognition site;
underlined: annealing sequence).
Additional file 4: Table S2. Vectors, plasmids in this study.Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
ND, MM and DM designed research; ND, MM, CB performed research; ND
and MM analyzed data; and ND, MM, CN, JT, DM wrote the paper. All
authors read and approved the final manuscript.
Acknowledgments
We wish to thank S. Buccato for helpful discussions about Gram-positive
expression systems, S. Pasquini for technical support in preparing the culture
media and M. Bottomley for valuable discussion and critical review of the
manuscript.ND is the recipient of a Novartis fellowship from the Ph.D. program in
Functional Biology of Molecular and Cellular Systems of the University of
Bologna.
Received: 3 September 2012 Accepted: 29 January 2013
Published: 1 February 2013References
1. Petsch D, Anspach FB: Endotoxin removal from protein solutions.
J Biotechnol 2000, 76:97–119.
2. Terpe K: Overview of bacterial expression systems for heterologous
protein production: from molecular and biochemical fundamentals to
commercial systems. Appl Microbiol Biotechnol 2006, 72:211–222.
3. Yang Y, Biedendieck R, Wang W, Gamer M, Malten M, Jahn D, et al: High
yield recombinant penicillin G amidase production and export into the
growth medium using Bacillus megaterium. Microb Cell Fact 2006,
5:36.
4. Udaka S, Yamagata H: High-level secretion of heterologous proteins by
Bacillus brevis. Methods Enzymol 1993, 217:23–33.
5. D'Urzo N, Malito E, Biancucci M, Bottomley MJ, Maione D, Scarselli M, et al:
The structure of Clostridium difficile toxin A glucosyltransferase domain
bound to Mn2+ and UDP provides insights into glucosyltransferase
activity and product release. FEBS J 2012, 279:3085–3097.
6. Tanio M, Tanaka T, Kohno T: 15N isotope labeling of a protein secreted by
Brevibacillus choshinensis for NMR study. Anal Biochem 2008,
373:164–166.
7. Guzman LM, Belin D, Carson MJ, Beckwith J: Tight regulation, modulation,
and high-level expression by vectors containing the arabinose PBAD
promoter. J Bacteriol 1995, 177:4121–4130.
8. Newman JR, Fuqua C: Broad-host-range expression vectors that carry the
L-arabinose-inducible Escherichia coli araBAD promoter and the araC
regulator. Gene 1999, 227:197–203.
9. Wegerer A, Sun T, Altenbuchner J: Optimization of an E. coli L-rhamnose
-inducible expression vector: test of various genetic module
combinations. BMC Biotechnol 2008, 8:2.
10. Kim L, Mogk A, Schumann W: A xylose-inducible Bacillus subtilis
integration vector and its application. Gene 1996, 181:71–76.
11. Rygus T, Hillen W: Catabolite repression of the xyl operon in Bacillus
megaterium. J Bacteriol 1992, 174:3049–3055.
12. Bhosale SH, Rao MB, Deshpande VV: Molecular and industrial aspects of
glucose isomerase. Microbiol Rev 1996, 60:280–300.
13. Lam VM, Daruwalla KR, Henderson PJ, Jones-Mortimer MC: Proton-linked D-
xylose transport in Escherichia coli. J Bacteriol 1980, 143:396–402.
14. Davis EO, Henderson PJ: The cloning and DNA sequence of the gene xylE
for xylose-proton symport in Escherichia coli K12. J Biol Chem 1987,
262:13928–13932.
15. Erbeznik M, Strobel HJ, Dawson KA, Jones CR: The D-xylose-binding
protein, XylF, from Thermoanaerobacter ethanolicus 39E: cloning,
molecular analysis, and expression of the structural gene. J Bacteriol
1998, 180:3570–3577.
16. Nakamura LK: Bacillus brevis Migula 1900 taxonomy: reassociation and
base composition of DNA. Int J Syst Bacteriol 1991, 41:510–515.
17. Sumiya M, Davis EO, Packman LC, McDonald TP, Henderson PJ: Molecular
genetics of a receptor protein for D-xylose, encoded by the gene xylF, in
Escherichia coli. Receptors Channels 1995, 3:117–128.
18. Shimomura O, Johnson FH, SAIGA Y: Extraction, purification and
properties of aequorin, a bioluminescent protein from the luminous
hydromedusan, Aequorea. J Cell Comp Physiol 1962, 59:223–239.
19. Yuuki T, Nomura T, Tezuka H, Tsuboi A, Yamagata H, Tsukagoshi N, et al:
Complete nucleotide sequence of a gene coding for heat- and pH-stable
alpha-amylase of Bacillus licheniformis: comparison of the amino acid
sequences of three bacterial liquefying alpha-amylases deduced from
the DNA sequences. J Biochem 1985, 98:1147–1156.
20. Sooriyaarachchi S, Ubhayasekera W, Park C, Mowbray SL: Conformational
changes and ligand recognition of Escherichia coli D-xylose binding
protein revealed. J Mol Biol 2010, 402:657–668.
21. Tsukagoshi N, Iritani S, Sasaki T, Takemura T, Ihara H, Idota Y, et al: Efficient
synthesis and secretion of a thermophilic alpha-amylase by protein-
producing Bacillus brevis 47 carrying the Bacillus stearothermophilus
amylase gene. J Bacteriol 1985, 164:1182–1187.
D’Urzo et al. Microbial Cell Factories 2013, 12:12 Page 11 of 11
http://www.microbialcellfactories.com/content/12/1/1222. Ichikawa Y, Yamagata H, Tochikubo K, Udaka S: Very efficient extracellular
production of cholera toxin B subunit using Bacillus brevis. FEMS
Microbiol Lett 1993, 111:219–224.
23. Ebisu S, Takagi H, Kadowaki K, Yamagata H, Udaka S: The efficient
production of human epidermal growth factor by Bacillus brevis.
Ann N Y Acad Sci 1996, 782:115–122.
24. Takimura Y, Kato M, Ohta T, Yamagata H, Udaka S: Secretion of human
interleukin-2 in biologically active form by Bacillus brevis directly into
culture medium. Biosci Biotechnol Biochem 1997, 61:1858–1861.
25. Rygus T, Scheler A, Allmansberger R, Hillen W: Molecular cloning, structure,
promoters and regulatory elements for transcription of the Bacillus
megaterium encoded regulon for xylose utilization. Arch Microbiol 1991,
155:535–542.
26. Biedendieck R, Yang Y, Deckwer WD, Malten M, Jahn D: Plasmid system for
the intracellular production and purification of affinity-tagged proteins
in Bacillus megaterium. Biotechnol Bioeng 2007, 96:525–537.
27. Aucoin MG, McMurray-Beaulieu V, Poulin F, Boivin EB, Chen J, Ardelean FM,
et al: Identifying conditions for inducible protein production in E. coli:
combining a fed-batch and multiple induction approach. Microb Cell Fact
2006, 5:27.
28. Krispin O, Allmansberger R: The Bacillus subtilis AraE protein displays a
broad substrate specificity for several different sugars. J Bacteriol 1998,
180:3250–3252.
29. Yamagata H, Adachi T, Tsuboi A, Takao M, Sasaki T, Tsukagoshi N, et al:
Cloning and characterization of the 5' region of the cell wall protein
gene operon in Bacillus brevis 47. J Bacteriol 1987, 169:1239–1245.
30. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, et al:
Gapped BLAST and PSI-BLAST: a new generation of protein database
search programs. Nucleic Acids Res 1997, 25:3389–3402.
31. Sagiya Y, Yamagata H, Udaka S: Direct high-level secretion into the culture
medium of tuna growth hormone in biologically active form by Bacillus
brevis. Appl Microbiol Biotechnol 1994, 42:358–363.
32. Cormack BP, Valdivia RH, Falkow S: FACS-optimized mutants of the green
fluorescent protein (GFP). Gene 1996, 173:33–38.
33. Klock HE, Koesema EJ, Knuth MW, Lesley SA: Combining the polymerase
incomplete primer extension method for cloning and mutagenesis with
microscreening to accelerate structural genomics efforts. Proteins 2008,
71:982–994.
34. Klock HE, Lesley SA: The Polymerase Incomplete Primer Extension (PIPE)
method applied to high-throughput cloning and site-directed
mutagenesis. Methods Mol Biol 2009, 498:91–103.
doi:10.1186/1475-2859-12-12
Cite this article as: D’Urzo et al.: High-level intracellular expression of
heterologous proteins in Brevibacillus choshinensis SP3 under the
control of a xylose inducible promoter. Microbial Cell Factories 2013 12:12.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
